Concepedia

David Monteith

DM

34

Publications

1.8K

Citations

21

H-Index

1985

Active since

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Eli Lilly (United States)

Duke Medical Center

The University of Texas Health Science Center at Houston

Altoona Center for Clinical Research

David Monteith is an author at Ionis Pharmaceuticals (United States) specializing in medicine, pharmacology, and toxicology.

Top concepts

Publications per year

1985–2018

34

Publications

34

Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

Kyle W. Sloop, Julia X.C. Cao, Angela M. Siesky et al. · Journal of Clinical Investigation · 2004 · 210 citations · Full text

Chemically Modified Oligonucleotides Exhibit Decreased Immune Stimulation in Mice

Scott P. Henry, Kim Stecker, Doug A. Brooks et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 146 citations

In Vivo Distribution and Metabolism of a Phosphorothioate Oligonucleotide within Rat Liver after Intravenous Administration

Mark Graham, Stanley T. Crooke, David Monteith et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 139 citations

Tissue Disposition of 2′‐O‐(2‐methoxy) ethyl Modified Antisense Oligonucleotides in Monkeys

Rosie Z. Yu, Richard S. Geary, David Monteith et al. · Journal of Pharmaceutical Sciences · 2003 · 104 citations

, , +4

Characterization of Oligonucleotide MetabolismIn Vivovia Liquid Chromatography/Electrospray Tandem Mass Spectrometry with a Quadrupole Ion Trap Mass Spectrometer

Richard H. Griffey, Michael J. Greig, Hans Gaus et al. · Journal of Mass Spectrometry · 1997 · 95 citations

Rows per page

1–5 of 34